Correlation Between Redhill Biopharma and Organogenesis Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Redhill Biopharma and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Redhill Biopharma and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Redhill Biopharma and Organogenesis Holdings, you can compare the effects of market volatilities on Redhill Biopharma and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Redhill Biopharma with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Redhill Biopharma and Organogenesis Holdings.

Diversification Opportunities for Redhill Biopharma and Organogenesis Holdings

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Redhill and Organogenesis is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Redhill Biopharma and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Redhill Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Redhill Biopharma are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Redhill Biopharma i.e., Redhill Biopharma and Organogenesis Holdings go up and down completely randomly.

Pair Corralation between Redhill Biopharma and Organogenesis Holdings

Given the investment horizon of 90 days Redhill Biopharma is expected to under-perform the Organogenesis Holdings. In addition to that, Redhill Biopharma is 1.85 times more volatile than Organogenesis Holdings. It trades about -0.05 of its total potential returns per unit of risk. Organogenesis Holdings is currently generating about 0.06 per unit of volatility. If you would invest  262.00  in Organogenesis Holdings on August 24, 2024 and sell it today you would earn a total of  140.00  from holding Organogenesis Holdings or generate 53.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Redhill Biopharma  vs.  Organogenesis Holdings

 Performance 
       Timeline  
Redhill Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Redhill Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Organogenesis Holdings 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Organogenesis Holdings are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Organogenesis Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.

Redhill Biopharma and Organogenesis Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Redhill Biopharma and Organogenesis Holdings

The main advantage of trading using opposite Redhill Biopharma and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Redhill Biopharma position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.
The idea behind Redhill Biopharma and Organogenesis Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like